The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states related to the activity of PARP, VEGFR2, and MLK3 enzymes, including, for example, neurodegenerative diseases, inflammation, ischemia, and cancer.

 
Web www.patentalert.com

< Aryl and heteroaryl compounds and methods to modulate coagulation

< Modified factor VIII

> Galectin 11

> Automatic portable pneumatic compression system

~ 00296